Petrichor Healthcare Capital Management specializes in healthcare investment and financial services, focusing on supporting world-class healthcare managers and businesses from company formation through late-stage and commercial growth opportunities. The firm adopts a long-term, strategic approach and leverages deep in-house scientific, technical, and commercial expertise to foster healthcare innovation. Petrichor typically engages in various investment rounds, including post-IPO equity and debt, as well as Series C and D rounds.
Notable portfolio companies include Aurion Biotech, ClearPoint Neuro, Fennec Pharmaceuticals, Palvella Therapeutics, Persivia, and Vero Biotech. These companies have collectively raised significant capital, demonstrating Petrichor's commitment to advancing healthcare solutions. The firm's investment philosophy centers on creating and identifying the next generation of healthcare innovation, providing not just capital but also strategic support to ensure the success of its portfolio companies.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
Top Investment Stages

Athyrium Capital Management
athyrium.com

Regal Healthcare Capital Partners
regalhcp.com

Patient Square Capital

Sio Capital Management
siocapital.com

Health Innovation Capital

Octagon Capital Advisors

Aquilo Capital Management
aquilocap.com

Parkman Healthcare Partners
parkmanhp.com

Health Catalyst Capital
SilverArc Capital
Aurora Funds
aurorafunds.com.au
Apothecary Capital
apothcap.com

Dorilton Capital
doriltongroup.com

NaviMed Capital Advisors
navimed.com

InnovaHealth Partners
HealthCor Partners

Aldrich Capital Partners
aldrichcap.com

Sectoral Asset Management
sectoral.com

Concord Health Partners
concordhp.com

Blue Ox Healthcare Partners
blueoxhcp.com
Vero Biotech